0 Commentaires
0 Parts
1561 Vue
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
- Connectez-vous pour aimer, partager et commenter!
- Anti-Metabolite Drugs Market: Cancer Treatment Innovations Driving Growth"In-Depth Study on Executive Summary Anti-Metabolite Drugs Market Size and Share Anti-metabolite drugs market is expected to gain market growth in the forecast period of 2022-2029. Data Bridge Market Research analyses the market to account to grow at a CAGR of 7.60% in the above mentioned forecast period. The Anti-Metabolite Drugs Market report contains market insights and analysis...0 Commentaires 0 Parts 1136 Vue
- Brigatinib API Market Growing at 8.1% CAGR Through 2034 GloballyAccording to a new report from Intel Market Research, the global Brigatinib API market was valued at USD 42.5 million in 2025 and is projected to reach USD 89.7 million by 2034, growing at a robust CAGR of 8.1% during the forecast period (2026–2034). This growth is propelled by the increasing global incidence of non-small cell lung cancer, particularly ALK-positive cases among...0 Commentaires 0 Parts 3146 Vue
- Crizotinib Drugs Market Growing at 6.7% CAGR Through 2034According to a new report from Intel Market Research, the global Crizotinib Drugs market was valued at USD 582.4 million in 2025 and is projected to reach USD 1,043.7 million by 2034, growing at a CAGR of 6.7% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of lung cancer, increasing adoption of molecular diagnostic testing for genetic...0 Commentaires 0 Parts 2716 Vue
- Global CT Simulators Market Growing at 5.4% CAGR Through 2034According to a new report from Intel Market Research, the global Computed Tomography (CT) Simulators market was valued at USD 1.02 billion in 2025 and is projected to reach USD 1.65 billion by 2034, growing at a CAGR of 5.4% during the forecast period (2025–2034). This growth is propelled by the rising global cancer burden, technological advancements in image-guided radiotherapy (IGRT),...0 Commentaires 0 Parts 2020 Vue
- Global Durvalumab Market Growing at 10.6% CAGR Through 2034According to a new report from Intel Market Research, the global Durvalumab Market was valued at USD 1.85 billion in 2025 and is projected to grow from USD 2.12 billion in 2026 to USD 4.76 billion by 2034, exhibiting a robust CAGR of 10.6% during the forecast period. Growth is driven by increasing cancer prevalence, advancements in immuno-oncology research, and rising investments in targeted...0 Commentaires 0 Parts 839 Vue
- Global Multi-target MET TKIs Market Growing at 7.6% CAGR Through 2034According to a new report from Intel Market Research, the global Multi-target MET TKIs market was valued at USD 1.52 billion in 2025 and is projected to reach USD 3.18 billion by 2034, growing at a CAGR of 7.6% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of non-small cell lung cancer and medullary thyroid cancer, precision oncology...0 Commentaires 0 Parts 2516 Vue
- Global Nimustine Hydrochloride Market Growing at 3.6% CAGR Through 2034According to a new report from Intel Market Research, the global Nimustine Hydrochloride market was valued at USD 78.5 million in 2024 and is projected to grow from USD 82.4 million in 2025 to USD 112.9 million by 2034, exhibiting a robust CAGR of 3.6% during the forecast period. Market growth is driven by increasing cancer prevalence, particularly in neurology and hematology applications,...0 Commentaires 0 Parts 108 Vue
- Global Selpercatinib Capsules Market Growing at 7.8% CAGR Through 2034According to a new report from Intel Market Research, the global Selpercatinib Capsules market was valued at USD 420 million in 2025 and is projected to reach USD 820 million by 2034, growing at a CAGR of 7.8% during the forecast period (2026–2034). This growth is propelled by the increasing prevalence of RET-altered cancers, growing adoption of biomarker-driven therapies, and...0 Commentaires 0 Parts 2886 Vue
- Global Superficial X-Ray Therapy System Market Growing at 4.7% CAGRAccording to a new report from Intel Market Research, the global Superficial X-Ray Therapy System market was valued at USD 312.5 million in 2025 and is projected to reach USD 472.8 million by 2034, growing at a CAGR of 4.7% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of non-melanoma skin cancers, increasing patient preference for...0 Commentaires 0 Parts 1953 Vue
Plus de résultats